Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial

Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.

from NYT > Health https://ift.tt/NdS7QyK
via health&fitness